Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Grifols SA (NASDAQ:GRFS)

21.86
Delayed Data
As of 4:00pm ET
 -0.47 / -2.10%
Today’s Change
14.27
Today|||52-Week Range
22.83
+36.03%
Year-to-Date

Today’s Trading

Previous close22.33
Today’s open22.36
Day’s range21.85 - 22.41
Volume466,311
Average volume (3 months)658,845
Market cap$5.8B
Dividend yield2.38%
Data as of 4:00pm ET, 06/26/2017

Growth & Valuation

Earnings growth (last year)+3.24%
Earnings growth (this year)--
Earnings growth (next 5 years)+12.39%
Revenue growth (last year)+2.94%
P/E ratio--
Price/Sales2.46
Price/Book3.88

Competitors

 Today’s
change
Today’s
% change
UTHRUnited Therapeutics ...+1.53+1.16%
VRXValeant Pharmaceutic...+1.28+8.10%
PTHNPatheon NV0.000.00%
IONSIonis Pharmaceutical...+0.53+0.96%
Data as of 4:02pm ET, 06/26/2017

Financials

Next reporting dateAugust 3, 2017
EPS forecast (this quarter)$0.29
Annual revenue (last year)$4.5B
Annual profit (last year)$602.1M
Net profit margin13.47%

Profile

Sector
Health Technology
Industry
Biotechnology
Joint Chief Executive Officer &
Director
Raimon Grifols Roura
Joint Chief Executive Officer &
Executive Director
Victor Grifols Deu
Corporate headquarters
Barcelona, Catalonia

Forecasts